Document:

exv10w1

Exhibit
10.1 

BROCADE SENIOR LEADERSHIP PLAN

Revised: December 19, 2008 (effective as of fiscal year 2009)

PURPOSE

     The Brocade Senior Leadership Plan is designed to link incentive compensation with Company
performance.

PERFORMANCE PERIOD AND PAYOUT PERIOD

     Performance against Company and individual objectives is measured annually (according to the
Company’s fiscal year) (Plan Period), but will be reviewed semi-annually. Payout of earned cash
bonuses, if any, occurs on an annual basis.

ELIGIBILITY

     Regular full-time and part-time Vice President (VP) level employees are eligible to participate in
the Senior Leadership Plan Program. To the extent a VP is eligible to and participates in the
Company’s Sales Incentive Plan, then that VP shall not be eligible to participate in this Senior
Leadership Plan.

     Participants must be regular (full-time or part-time) employees at the end of the fiscal year to be
eligible to receive a Senior Leadership Plan Payout.

PARTICIPANT PERFORMANCE

     As each Plan Period begins, participants must complete a CEO or VP Performance Contract.
Performance contracts should be tied to company and departmental goals as outlined by the board of
directors (i.e., company priorities and initiatives). All goals must be tied to overall company
objectives and have defined measurements.

     Before Performance Contracts for Executive VPs are final, they are to be reviewed and approved by
Finance, Human Resources, and the Chief Executive Officer (CEO). Performance Contracts for
Functional VPs are reviewed and approved by the applicable Executive VP. The CEO’s Performance
Contract shall be reviewed by the Chair of the Board of Directors and the Chair of the Compensation
Committee.

     At the end of each Plan Period, actual performance against the plan’s financial metric goals is
determined by Finance and provided to the plan participants. Performance against goals is then
assessed by the Participant and then reviewed and assessed by the VP’s manager, in order to
determine each participant’s bonus payout for the period. The Compensation Committee reviews and
approves all Section 16 Officers’ performance and bonus payouts annually. The CEO reviews and
approves all other VP cash bonus payouts. The Compensation Committee shall review and approve the
CEO’s bonus payouts.

1.

 

COMPANY PERFORMANCE & SENIOR LEADERSHIP PLAN FUNDING

     Each Plan Period, Brocade’s Board of Directors will set a Non-GAAP Operating Income target for the
Company to achieve during the Plan Period (Target OI).

     At the end of each Plan Period, Brocade will determine amounts to be paid under the Senior
Leadership Plan based on the actual performance achieved by Brocade during the Plan Period (Actual
OI) relative to the Target OI (Actual Funding).

     The Actual OI will be communicated following the end of each Plan Period.

PARTICIPANT INCENTIVE TARGET

     With respect to Section 16 Officers (including the Chief Executive Officer), a Participant’s Annual
Incentive Target may range from 40% to 150% and is determined by the Company’s Compensation
Committee. With respect to other participants in the Company’s Senior Leadership Plan, a
Participant’s Annual Incentive Target is determined by the Participant’s classification or pay
grade at the end of the 12-month Plan Period, unless otherwise indicated in writing by Brocade.

SENIOR LEADERSHIP PLAN PAYOUTS

     On an annual basis, the Compensation Committee reviews and approves the formula for cash bonus
payouts for all Section 16 Officers (including the CEO) and the Individual Performance for Section
16 Officers other than the CEO. The CEO reviews and approves the formula for cash bonus payouts and
the Individual Performance for all other VP cash bonuses. Individual Performance can range from
90% to 100%. The CEO is measured exclusively on Corporate performance.

     Program payouts are made within eight (8) weeks following the conclusion of the 12-month Plan
Period. Payouts will be pro-rated for Participants who are hired or transferred into the Senior
Leadership Plan during any Plan Period.

     Except as otherwise agreed upon by: (i) the Compensation Committee for the CEO and other Section
16 officers, and the CEO for all other VPs, and (ii) the Participant, for each Participant, the
cash bonus payout is calculated based on the following formula (less applicable taxes and
deductions):

     Bonus Payout = (Actual Funding) x (Individual Performance*) x (Annual Incentive
Target) x (Annual Salary)

			
	*	 	Individual Performance scoring is not applicable to the CEO.

     Bonuses will be calculated using the annual base salary and Annual Incentive Target as of the last
day of the Plan Period, except as set forth above or otherwise indicated in writing by Brocade.

2.

 

ADMINISTRATIVE PROCEDURES

Compensation Committee Approval

     The Compensation Committee reserves the right to decrease or eliminate bonus otherwise indicated.

New Hires and Promotions

     Participants new to the company or who are promoted into the Senior Leadership Plan must complete a
VP Performance Contract within 60 days of beginning in the new position.

Position/Salary Factor

     Payout will be based on the Participant’s annual base salary and job position on the last day of
the Plan Period. Bonuses may be pro-rated if Participant received a cash bonus under another bonus
program.

     Terminations: Anyone who is not on the payroll as of the end of the fiscal year is not eligible to
receive a cash bonus payout.

     Leaves of Absences, Disability or Death: In the event of the Participant’s death, disability time
off, or leave of absence, Payouts will be made on a pro-rated basis, based on the number of days
the Participant was actively working at Brocade. If the Participant is on a legally protected leave
of absence (e.g. Family Medical Leave or Military Leave), the Participant’s eligibility for
participation in Plan may be extended beyond the time above, in accordance with the laws governing
the legally protected leave. In the event of death, any cash bonus payments will be paid to the
Participant’s primary beneficiary as designated in the Participant’s Brocade life insurance plan
documentation, if any, or will otherwise be paid to his or her estate.

     Performance Improvement Plan/Disciplinary Situations (Development Needed): If a Participant, at
anytime prior to the cash bonus payout 12-month Plan Period, is subject to a performance
improvement plan, discipline or demotion, Brocade may, in its sole discretion, reduce or eliminate
the cash bonus payment that the Participant would otherwise have been eligible to receive. If, at
the time prior to the Payout for a 12-month Plan Period, it is determined that a Participant may be
subject to corrective action, discipline or demotion, then Brocade may withhold the entire cash
bonus payout, or a portion thereof, until after a final decision on such corrective action has been
made. If a Participant is given a performance rating of Development Needed, the Participant will
not be eligible to receive a Payout. Only the VP of Human Resources or CEO may approve exceptions
to this policy, except that the Compensation Committee must approve exceptions for Section 16
officers.

     Other Provisions: Participation in the Senior Leadership Plan does not constitute an agreement
(express or implied) between the Participant and Brocade that the Participant will be employed by
Brocade for any specific period of time, nor is there any agreement for continuing or long-term
employment. Terms and conditions regarding the Senior Leadership Plan and any participation
therein, including but not limited to Senior Leadership Plan eligibility, Senior Leadership Plan
funding, and performance and payout criteria and determinations, are subject to change by Brocade
at any time in its sole discretion. Brocade and its Board of Directors retain
the absolute right to interpret, revise, modify or terminate the Senior Leadership Plan at any time
in its sole discretion.

3.exv10w1

Exhibit 10.1

VIA PHARMACEUTICALS, INC.

RESTRICTED STOCK AGREEMENT

	 	 	 
	Name:

	 	VIA Pharmaceuticals, Inc.
	 

	 	2007 Incentive Award Plan
	Address:
	 	 
	 

	 	Total number of shares of Restricted Stock                    
	 
	 	 
	 

	 	Purchase Price: $0.00
	Taxpayer
	 	 
	Identification Number:

	 	Grant Date:
	 
	 	 
	 

	 	Vesting Commencement Date:
	Signature:
	 	 

     1. Restricted Stock Grant. Effective on the Grant Date, you have been granted an
award of restricted Common Stock of VIA Pharmaceuticals, Inc. (the “Company”) in the amount and at
the purchase price designated above (the “Restricted Stock”), in accordance with the provisions of
the VIA Pharmaceuticals, Inc. 2007 Incentive Award Plan (the “Plan”). This grant of Restricted
Stock is being made in consideration of your past and/or continued employment with or service to
the Company and for other good and valuable consideration which the Committee has determined
exceeds the aggregate par value of the shares subject to the Restricted Stock award.

     2. Vesting Schedule and Release. The Restricted Stock shall be subject to certain
restrictions and risks of forfeiture as set forth in Section 5 (the “Restrictions”). Subject to
Section 5 below, the shares shall vest according the following schedule:

     One twenty fourth (1/24th) of the shares (rounded down to
the next whole number) shall vest and the Restrictions with respect thereto
shall lapse monthly following the Vesting Commencement Date on the same day
of the month as the Vesting Commencement Date, such that the shares subject
to the Restricted Stock award are fully vested and all Restrictions with
respect thereto shall have lapsed at 24 months following the Vesting
Commencement Date.

     Notwithstanding the foregoing, the Restricted Stock shall vest and the
Restrictions with respect thereto shall lapse on the date that the Committee
determines, in its sole discretion, that the Company has entered into a
partnering transaction with a pharmaceutical or biotechnology company with
respect to conducting follow-on clinical trials which are reasonably
expected to result in further progress of VIA-2291 toward ultimate
registration with the U.S. Food and Drug Administration.

     In the event of the termination of your employment or service for any reason, whether such
termination is occasioned by you, by the Company or any of its subsidiaries, with or without cause
or by mutual agreement (“Termination of Service”), your right to vest in your Restricted Stock
under the Plan, if any, will terminate effective as of the earlier of: (i) the date that you give
or are provided with written notice of Termination of Service, or (ii) if you are an employee of
the Company or any of its subsidiaries, the date that you are no longer actively employed and
physically present on the premises of the Company or any of its Subsidiaries, regardless of any
notice period or period of pay in lieu of such notice required under any applicable statute or the
common law.

 

 

     3. Restricted Stock Account; Escrow. Unless and until the shares of Restricted Stock
have vested in the manner required under this Agreement, at the Company’s discretion, the shares
shall be held in escrow by the Company or its designee, or deposited in a restricted stock account
for you at the Company’s transfer agent with appropriate notations regarding the restrictions on
transfer imposed pursuant to this Agreement. The Company reserves the right in its sole discretion
to change the financial institution in which the shares are deposited, if applicable. You agree to
execute any documentation reasonably necessary to effectuate any escrow or deposit with a transfer
agent of the shares of Restricted Stock. The certificate or certificates representing the
Restricted Stock will not be delivered to you unless and until the shares have vested pursuant to
the terms of the Plan and this Agreement and all other terms and conditions in this Agreement and
under the Plan have been satisfied.

     4. Rights as Stockholder. You shall have none of the rights or privileges of a
stockholder of the Company in respect of the Restricted Stock deliverable under the Agreement
unless and until certificates representing such shares shall have been issued and recorded on the
records of the Company or its transfer agents or registrars. After such issuance and recordation,
you shall have all the rights of a stockholder of the Company with respect to voting such shares
and receipt of dividends and distributions on such shares.

     5. Restrictions and Forfeiture. You shall not sell, pledge, transfer, subject to
lien, assign or otherwise hypothecate any shares of Restricted Stock unless and until the shares
have vested, and certificates have been issued, recorded and delivered and all other terms and
conditions set forth in this Agreement and the Plan have been satisfied (the “Restrictions”). Any
attempt to do so contrary to the provisions of this Agreement shall be null and void. The balance
of any shares of Restricted Stock that have not vested shall be forfeited in the event of your
Termination of Service for any reason prior to the applicable vesting date.

     6. No Additional Rights. Your participation in the Plan is voluntary. The value of
the Restricted Stock is an extraordinary item of compensation outside the scope of your employment
contract, if any. As such, the Restricted Stock is not part of normal or expected compensation for
purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses,
long-service awards, pensions or retirement benefits or similar payments unless specifically and
otherwise provided. Rather, the awarding of the Restricted Stock under the Plan represents a mere
investment opportunity.

     7. Limitations on Plan Rights. The Restricted Stock is granted under and governed by
the terms and conditions of the Plan. You acknowledge and agree that the Plan is discretionary in
nature and may be amended, cancelled, or terminated by the Company, in its sole discretion, at any
time. This grant of Restricted Stock under the Plan is a one-time benefit and does not create any
contractual or other right to receive additional grants or benefits in the future. Future grants
of awards, if any, will be at the sole discretion of the Company, including, but not limited to,
the timing of the grant, the number of shares, vesting provisions, and the purchase price. The
Plan has been introduced voluntarily by the Company and in accordance with the provisions of the
Plan may be terminated by the Company at any time. By execution of this Agreement, you consent to
the provisions of the Plan and this Agreement. Defined terms used herein shall have the meaning
set forth in the Plan, unless otherwise defined herein. The terms of this Agreement are intended
to be in full accordance with the Plan. However, in the event of any potential conflict between
any term of this Agreement and the Plan, this Agreement shall automatically be amended to comply
with the terms of the Plan.

     8. Entire Agreement; Governing Law. The Plan is incorporated herein by reference.
The Plan and this Restricted Stock Agreement constitute the entire agreement of the parties with
respect to the subject matter hereof and supersede in their entirety all prior undertakings and
agreements of the Company and you with respect to the subject matter hereof, and may not be
modified adversely to your
interest except by means of a writing signed by you and the Company. This Agreement is
governed by the internal substantive laws but not the choice of law rules of California.

2

 

     9. No Guarantee of Continued Service. YOU ACKNOWLEDGE AND AGREE THAT THE VESTING OF
SHARES PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING AS AN ELIGIBLE
INDIVIDUAL AT THE WILL OF THE COMPANY (NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS
RESTRICTED STOCK OR ACQUIRING SHARES HEREUNDER). YOU FURTHER ACKNOWLEDGE AND AGREE THAT THIS
AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT
CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS AN ELIGIBLE INDIVIDUAL FOR THE
VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND SHALL NOT INTERFERE IN ANY WAY WITH YOUR RIGHT OR
THE COMPANY’S RIGHT TO TERMINATE YOUR RELATIONSHIP AS AN ELIGIBLE INDIVIDUAL AT ANY TIME, WITH OR
WITHOUT CAUSE.

     10. Tax Withholding and Section 83(b) Election. The Company shall be entitled to
require a cash payment by you or on your behalf and/or to deduct from other compensation payable to
you any sums required by federal, state or local tax law to be withheld with respect to the grant
or vesting of the Restricted Stock or the lapse of the Restrictions hereunder. You understand that
Section 83(a) of the Internal Revenue Code taxes as ordinary income the difference between the
amount, if any, paid for the Restricted Stock and the Fair Market Value of such shares at the time
the Restrictions on such shares lapse. You understands that, notwithstanding the preceding
sentence, you may elect to be taxed at the time of the Grant Date, rather that at the time the
Restrictions lapse, by filing an election under Section 83(b) of the Code (an “83(b) Election”)
with the Internal Revenue Service within 30 days of the Grant Date. In the event you file an 83(b)
Election, you shall provide the Company a copy thereof prior to the expiration of such 30 day
period. You understand that in the event an 83(b) Election is filed with the Internal Revenue
Service within such time period, you will recognize ordinary income in an amount equal to the
difference between the amount, if any, paid for the Restricted Stock and the Fair Market Value of
such shares as of the Grant Date. You further understand that an additional copy of such 83(b)
Election form should be filed with your federal income tax return for the calendar year in which
the date of this Agreement falls. You acknowledge that the foregoing is only a summary of the
effect of United States federal income taxation with respect to the grant of Restricted Stock
hereunder, and does not purport to be complete.

     YOU FURTHER ACKNOWLEDGE THAT THE COMPANY IS NOT RESPONSIBLE FOR FILING YOUR 83(b) ELECTION,
AND THE COMPANY HAS DIRECTED YOU TO SEEK INDEPENDENT ADVICE REGARDING THE APPLICABLE PROVISIONS OF
THE INTERNAL REVENUE CODE, THE INCOME TAX LAWS OF ANY MUNICIPALITY, STATE OR FOREIGN COUNTRY IN
WHICH YOU MAY RESIDE.

     YOU HEREBY ASSUME ALL RESPONSIBILITY FOR FILING YOUR 83(b) ELECTION AND PAYING ANY TAXES
RESULTING FROM SUCH ELECTION OR FROM FAILURE TO FILE THE ELECTION AND PAYING TAXES RESULTING FROM
THE LAPSE OF THE RESTRICTIONS ON THE UNVESTED SHARES.

     YOU UNDERSTAND THAT YOU MAY SUFFER ADVERSE TAX CONSEQUENCES AS A RESULT OF YOUR PURCHASE OR
DISPOSITION OF THE SHARES AND YOU REPRESENT THAT YOU ARE NOT RELYING ON THE COMPANY FOR ANY TAX
ADVICE.

3

 

     You acknowledge receipt of a copy of the Plan and represent that you are familiar with the
terms and provisions thereof, and hereby accept this award of Restricted Stock subject to all of
the terms and

provisions thereof. You have reviewed the Plan and this Agreement in their entirety, have had
an opportunity to obtain the advice of counsel prior to executing this Agreement and fully
understand all provisions of the Agreement. You hereby agree to accept as binding, conclusive and
final all decisions or interpretations of the Committee upon any questions arising under the Plan
or this Agreement. You further agree to notify the Company upon any change in the residence
address indicated above.

COMPANY:

VIA PHARMACEUTICALS, INC.

	 	 	 	 	 
	By:
	 	 	 	 
	 

	 	 

	 	 
	Its:
	 	 	 	 
	 

	 	 	 	 

4

 

EXHIBIT A

TO RESTRICTED STOCK AGREEMENT

CONSENT OF SPOUSE

     I,                                         , spouse of                     , have read and approve the
 foregoing
Agreement. In consideration of issuing to my spouse the shares of the common stock of VIA
Pharmaceuticals, Inc. set forth in the Agreement, I hereby appoint my spouse as my attorney-in-fact
in respect to the exercise of any rights under the Agreement and agree to be bound by the
provisions of the Agreement insofar as I may have any rights in said Agreement or any shares of the
common stock of VIA Pharmaceuticals, Inc. issued pursuant thereto under the community property
laws or similar laws relating to marital property in effect in the state of our residence as of the
date of the signing of the foregoing Agreement.

Dated:                     , ___

                                                            

Signature of Spouse

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00151-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00151-of-00352.parquet"}]]